Acrivon Therapeutics News

Acrivon Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Miller Mary

Apr 19 15:15

Acrivon Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director RA CAPITAL MANAGEMENT, L.P.

Apr 15 15:20

Acrivon Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner PERCEPTIVE ADVISORS LLC

Apr 15 07:58

Acrivon Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Perceptive Advisors LLC(17.4%),Joseph Edelman(17.4%), etc.

Apr 15 07:23

Acrivon Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(27.1%),Peter Kolchinsky(27.1%), etc.

Apr 11 15:22

Acrivon Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Palani Santhosh

Mar 6 15:36

Acrivon Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Palani Santhosh

Mar 6 15:31

Acrivon Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Masson Kristina

Feb 16 16:19

Acrivon Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Miller Mary

Feb 16 16:18

Acrivon Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Holm-Jorgensen Rasmus

Feb 16 16:17

Acrivon Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Devroe Eric

Feb 16 16:13

Acrivon Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Gamelin Erick

Feb 16 16:13

Acrivon Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Blume-Jensen Peter

Feb 16 16:08

Acrivon Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Perceptive Advisors LLC(13.6%),Joseph Edelman(13.6%), etc.

Feb 14 16:37

Acrivon Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Citadel Advisors LLC(7.4%),Citadel Advisors Holdings LP(7.4%), etc.

Feb 14 16:02

Acrivon Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Marshall Wace North America L.P.(2.7%)

Feb 14 08:57

Acrivon Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Sands Capital Life Sciences Pulse Fund II, L.P.(7.4%),Sands Capital Ventures, LLC(7.4%), etc.

Feb 13 14:45

Acrivon Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Magovcevic-Liebisch Ivana

Feb 9 15:41

Acrivon Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Magovcevic-Liebisch Ivana

Feb 9 15:36

Acrivon Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Miller Mary

Jan 18 23:00